Sitemap
Home
About
Executive Management
Board of Directors
Contact Information
Directions to Geron
Affiliates
Geron Bio-Med Ltd
Licensees
Viagen
Merck
Roche
Sienna
Careers
Open Positions
Job Description
Benefits
How to Apply
Contact
Contact Information
GRNOPC1 Home
About GRNOPC1
News Release
Investors
Product Pipeline
News Releases
Annual Reports
Events
Corporate Governance
Investor Contacts
Information Request
Media
News Releases
Events
Media Contacts
Patients
Clinical Trial Information
Oncology
Imetelstat - Telomerase Inhibitor Drug
GRNVAC1 - Telomerase Cancer Vaccine
Regenerative Medicine
GRNOPC1 - hESC-Derived Glial Cells
Disease Information
Cancer
Spinal Cord Injury
Heart Disease
Diabetes
Information Request
Products
Imetelstat - Telomerase Inhibitor Drug
GRNVAC1/GRNVAC2 - Telomerase Cancer Vaccine
GRNOPC1 - hESC-Derived Glial Cells
GRNCM1 - hESC-Derived Cardiomyocytes
GRNIC1 - hESC-Derived Islet Cells
GRNCHND1 - hESC-Derived Chondrocytes
hESC-Derived Osteoblasts
hESC-Derived Cells for Drug Screening
Technology & Science
Telomerase
Selected Publications
Human Embryonic Stem Cells
Selected Publications
Stem Cell Lines
Nuclear Transfer
Glossary
Patents
Search